Trabajos de fin de máster

Evaluation of the anti-neuroinflammatory effects of compound CH213. Lucía Viqueira-Diaz Alejo. Julio 2021.

NRF in Alzheimer´s disease: Update on current pharmacological approaches to induce NRF2 activity. Marcos Martínez. Julio 2020.

Pharmacological characterization of melatonin and resveratrol derivatives for potential Alzheimer’s Disease treatments. Eric del Sastre López. Septiembre 2019.

Multitarget compounds for the treatment of Alzheimer’s disease. José Lombardía Gutiérrez. Septiembre 2018.

NOX4 contribution in a neurodegenerative tauopathy model. Paula Trigo Alonso. Septiembre 2017.